社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
Hk01
IP属地：未知
+关注
帖子 · 99
帖子 · 99
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Hk01
Hk01
·
2021-12-16
An Apple a day cost about $170.
非常抱歉，此主贴已删除
看
977
回复
评论
点赞
1
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-16
We’ll see in time if it’s really good.
The Next Top Electric Vehicle Stock: Look Out Tesla And Apple
Summary Semiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Mi
The Next Top Electric Vehicle Stock: Look Out Tesla And Apple
看
1,294
回复
评论
点赞
2
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-16
Really
非常抱歉，此主贴已删除
看
1,422
回复
1
点赞
4
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-14
Ok
非常抱歉，此主贴已删除
看
1,304
回复
评论
点赞
6
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-14
Really
5 Stocks To Watch For December 13, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Qudian Inc. to repor
5 Stocks To Watch For December 13, 2021
看
1,485
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-13
Nice
Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%
Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove
Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%
看
1,112
回复
1
点赞
3
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-10
Wow
Vaccine stocks dropped in morning trading
Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.
Vaccine stocks dropped in morning trading
看
941
回复
评论
点赞
3
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-09
Wow
Pear Therapeutics shares soared 75% in premarket trading
Pear Therapeutics shares soared 75% in premarket trading. Prescription digital therapeutics company
Pear Therapeutics shares soared 75% in premarket trading
看
1,055
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-09
Ok
U.S. Stock Futures Wobble on Omicron Restrictions
U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit th
U.S. Stock Futures Wobble on Omicron Restrictions
看
1,157
回复
评论
点赞
3
编组 21备份 2
分享
举报
Hk01
Hk01
·
2021-12-08
Cool
Pfizer, BioNTech say third dose neutralizes Omicron variant
Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on
Pfizer, BioNTech say third dose neutralizes Omicron variant
看
1,332
回复
评论
点赞
6
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4092737844653660","uuid":"4092737844653660","gmtCreate":1629940275744,"gmtModify":1630212260093,"name":"Hk01","pinyin":"hk01","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":11,"tweetSize":99,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.24","exceedPercentage":"60.63%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":690348613,"gmtCreate":1639642425794,"gmtModify":1639642425968,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"An Apple a day cost about $170. ","listText":"An Apple a day cost about $170. ","text":"An Apple a day cost about $170.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690348613","repostId":"1168308155","repostType":4,"isVote":1,"tweetType":1,"viewCount":977,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690341553,"gmtCreate":1639642306522,"gmtModify":1639642321291,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"We’ll see in time if it’s really good. ","listText":"We’ll see in time if it’s really good. ","text":"We’ll see in time if it’s really good.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690341553","repostId":"1162833574","repostType":4,"repost":{"id":"1162833574","kind":"news","pubTimestamp":1639638037,"share":"https://www.laohu8.com/m/news/1162833574?lang=&edition=full","pubTime":"2021-12-16 15:00","market":"us","language":"en","title":"The Next Top Electric Vehicle Stock: Look Out Tesla And Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=1162833574","media":"Seeking Alpha","summary":"Summary\n\nSemiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Mi","content":"<p><b>Summary</b></p>\n<ul>\n <li>Semiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Microchip Technology are EV semiconductor stocks to watch.</li>\n <li>The auto sector took a beating during the pandemic but is rebounding. Some EV stocks look attractive given the political environment, rising gas prices, and expansion of charging stations.</li>\n <li>In 2022, US auto sales are expected to increase to $16M from $15M. Top automaker Ford wants all-in on electric and is addressing the chip shortage their way.</li>\n <li>Compared to its EV rivals Tesla and Apple, Ford offers solid fundamentals, a reasonable valuation framework, excellent Quant Factor grades, upward earnings revisions, and incredible stock momentum.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5fe8b143e1df1016169fd2775f2f9d27\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Bill Pugliano/Getty Images News</span></p>\n<p>Automobiles and Semiconductor Chip Shortage</p>\n<p>Over the last several years, the rapid growth of Electric Vehicles (EV) has been nothing short of astonishing. As Brendan Ahern said in his article,The Unstoppable EV Ecosystem And How To Invest, \"The past two years have seen tremendous excitement in the global electric vehicles (EVs) industry as new companies listed shares, Tesla (TSLA) was added to the S&P 500, global governments stepped up electrification commitments, and electric vehicle sales soared, especially in China and the EU.\" This overview sums up the progress of EVs in the auto sector.</p>\n<p>Our Top Automotive pick, Ford (F), is up 132% YTD and is in an enviable position on fundamentals at this time compared to Tesla, up 37% YTD. And despite Apple's (AAPL) accelerating plans for an autonomous vehicle, which they have deemed their mother of all Ai projects, so far, they are all talk with no viable EV product offering. Apple’s entry into the autonomous vehicle space is a topic of speculation. Notably, there is more than one way to invest in the EV revolution. It comes down to \"what’s inside?\"</p>\n<p>Cars are like the new mainframe computers. A new car can have more than two thousand chips, blowing away a smartphone with perhaps four chips. Semiconductors play a significant role in today's automotive sector, especially EVs, which is why we find their stocks attractive. ON Semi (ON), Qualcomm (QCOM), and Microchip Technology (MCHP) are some of the best suppliers for the automotive sector. Supply chain constraints and Asian factory shutdowns have drastically impacted automotive sales. Despite the supply shortage, there's been high demand, and we've seen the cost of semiconductor shortages balloon above 90%, according to a Bloomberg News Article.</p>\n<p>With a record 21 weeks to fill chip orders,Dan Hearsch, Managing Director of AlixPartners Automotive and Industrial Practice said, \"It certainly feels like the most protracted supply shortage the industry has seen because it's not over.\" Despite the lack of semiconductors, automotive prices continue to climb, reaching records in the U.S. over $42,000 per vehicle, making chip manufacturers like ON Semi, Qualcomm, and Microchip Technology Incorporated Very Bullish buys, especially given their demand in EVs.</p>\n<p><b>ON Semiconductor Corporation</b></p>\n<p>ON Semiconductor is a stock I recently wrote about in an article called Top 5 Tech Stocks For 2022. A Fortune 1000 Company, ON Semi is a semiconductor and leading power management provider that uses signal and custom device technologies for communications, automotive, computing, and other uses. EV advancements allow for increased use of semiconductors in-vehicle platforms' electronics content, improving occupant safety through imaging and sensor function technology; sensor functions by way of algorithms enable vehicles to take immediate action to avoid accidents. This electrification is also used in the powertrain and vehicle auxiliary systems, with semiconductor technology at the forefront.</p>\n<p>The Seeking Alpha News Team recently reported ON Semi as a top pick at Citigroup. Citigroup analyst Christopher Danely said, \"With January's earnings season on the horizon, now is a prime time for investors to buy semiconductor stocks as chip-sector shortages don't appear to be getting better any time soon...Danelynotes that business conditions for the semiconductor industry have not been this strong since 1999 and 2000 and that \"many\" companies are booked solid with orders through 2022.\"</p>\n<p>ON carries a C+ Valuation Grade, remaining attractive relative to its sector by more than 7.29%, at a Forward P/E of 22.43x. Additionally, ON's growth, profitability, and momentum metrics are attractive.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/041f800d3cc6cb924bd6d61c64faf92e\" tg-width=\"640\" tg-height=\"394\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Momentum is a strong A+ Grade for ON Semiconductor, as they continue to have stellar price returns, with a price-performance return over 10 years exceeding 700%. Diving into ON’s growth grades, the company has a strong year-over-year EBITDA Growth grade of A- at 134.70% above the sector, and EPS FWD Long Term grade of A+, 208% above the sector. As we continue to dive into semiconductors important to vehicle automation, there is another name in the chip industry helping increase the trend towards EVs.</p>\n<p><b>Qualcomm</b></p>\n<p>QCOM gets a significant portion of its revenue from products aimed at the automotive sector. QCOM is already the world's biggest supplier of mobile phone chips, a wireless technology innovator, and 5G driver. The company has announced it will continue to expand into next-generation self-driving vehicles. SA news just reported Qualcomm could rally 25% higher in the next six months, according to Cerity Partners' Jim Lebenthal. Qualcomm, who already works with firms like Microsoft (MSFT) and Meta Platforms (FB), wants to grab hold of the EV market share, which is significantly higher than the phone chip industry, according to Cristiano Amon, QCOM President and CEO. In a November Press Release, Amon said, \"Our announcement with BMW today is the onset of a new era in automotive where two technology leaders have come together to design and develop…the next-generation automobile…we see an incredible number of changes in the industry that are driving things and putting Qualcomm at the intersection of demand for virtually every industry.\"</p>\n<p>When looking at QCOM's Factor Grades below, it's clear why we believe they are on solid footing.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee2ff7cc1f310c6f8fd1e875afacc02e\" tg-width=\"284\" tg-height=\"223\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>QCOM comes at a reasonable valuation, trading nearly 30% below its sector with a forward P/E of 17.27+; Forward PEG is almost 63% below the sector. The stock has strong growth, excellent profitability metrics, and many analysts increasing their earnings estimates. As fellow Seeking Alpha author Valuentum writes, \"Qualcomm's growth trajectory is supported by its push into the automotive arena and the IoT trend, which are expected to grow its total addressable market opportunity over the next decade.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14b7d462d95760ddddea06904c48c60a\" tg-width=\"640\" tg-height=\"430\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>In addition to its strong profitability, QCOM is one of the best dividend-paying technology stocks. QCOM has a Dividend Growth Grade of A+. Because the trend and rise in popularity of electric vehicles is not the only way to make money, we are emphasizing another top semiconductor leading the wave of rising EVs, Microchip Technology Incorporated (MCHP).</p>\n<p><b>Microchip Technology Incorporated</b></p>\n<p>Another top EV chip-maker is MCHP, whose chips are used in wireless apps and devices for power management. MCHP’s chips specifically designed for electric vehicles is the artificial intelligence used to centralize computing and navigation and the powertrains and charging systems. Rated Very Bullish, out of 557 of our Top Tech Stocks, MCHP is ranked in the top 10% of this screener and continues to be on an upward trajectory, as evidenced by its B+ Momentum Grade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/38fa9b58f8f38267e8104688a79b1c77\" tg-width=\"640\" tg-height=\"204\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Following recent Q2 Earnings results,Jefferies Financial Group, among other analysts, has increased their MCHP price target of $98 to $109, which implies a 22.7% upside. With an EPS of $1.07 that beat by $0.01 and Revenue of $1.65B beating nearly 26% YoY, it’s no wonder there are 21 FY1 Up Revisions in the last 90 days, prompting an A- Revisions Grade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fc325cd371e06ec406b8e454cf7c4670\" tg-width=\"640\" tg-height=\"183\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>As we look to the EV sector capitalizing on the use of semiconductors and investors wanting to know more about stocks in this space, let us discuss Ford (F), who recently partnered with GlobalFoundries (GFS), a multinational semiconductor manufacturing and design company to address the semiconductor shortage, thus positioning themselves as the next prominent EV manufacturer to rival Tesla and Apple in the space.</p>\n<p><i><b>YTD F, AAPL, TSLA PRICE RETURN COMPARISON</b></i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f2175c40e8df25d2f22ed2e219327137\" tg-width=\"640\" tg-height=\"230\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p><b>Ford</b></p>\n<p>Ford has been a differentiator since the invention of the automobile. Ford’s partnering with semiconductor company GlobalFoundries clarifies that it wants to lead the industry and evolve by all means necessary, striking deals with companies to source materials and the parts required to avoid supply chain disruptions. \"Semiconductor is going to become the defining line for differentiation in the automotive experience. I believe you're seeing automotive companies want to become what I would call more silicon aware. And that's exactly what Ford is doing in their MOU they signed with G.F. They want to first make sure that they understand the supply-demand dynamics… to make sure they influence the technology road maps for foundries so that the features that we create align with their needs,\"Tom Caulfield GFS CEO, Q3 2021 Earnings Call. So how does Ford compare to its E.V. rivals, Tesla and Apple, in the electric car race?</p>\n<p><b>Ford Valuation vs. Tesla and Apple</b></p>\n<p>Ford is undervalued with an overall valuation grade of C, forward P/E trading -25.82%, and the sector at 14.55X. The forward PEG ratio has an A+ grade, trading nearly 82% below the sector. When we compare Ford, Apple, and Tesla on Valuation, TSLA and AAPL receive an overall F Grade.</p>\n<p>Compared to Tesla and Apple with F Valuation Grades, both look unattractive on a PEG basis (P/E Ratio divided by EPS long-term growth). Tesla PEG of 3.52X is 263.70% above the sector, and Apple PEG of 2.81X, 70.78% above the sector.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/54c31cedfc851a3fb1072546e0b5c879\" tg-width=\"640\" tg-height=\"440\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Seeking Alpha’s Valuation Grade provides a unique view of how much a company is worth relative to other stocks in the same sector. Thanks to dozens of underlying metrics, the grades provide an instant characterization of the strength or weakness of the metric compared to similar stocks. Ford looks attractive on a 0.17X PEG basis and is not overvalued compared to the sector, with a median PEG of 0.97X.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbb961e840c6250e27933fd611faefc6\" tg-width=\"640\" tg-height=\"244\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>While a C grade is not ideal, Ford still looks attractive. As a pioneer in its industry, it should fare well in the EV space. According to Aswath Damodaran,Professor of Finance at the Stern School of Business at N.Y. University, the Automotive and Truck sector is sitting pretty, with a current P/E of 164.37 based upon January 2021 data and expected growth of 18.8% over the next five years with a PEG ratio of 8.87.</p>\n<p>Apple's announcement of a fully autonomous vehicle has turned heads, especially given its wide range of technology and persistent delays to the project.Apple Car Project is being led by Ai and machine learning Chief John Giannandrea. \"We're focusing on autonomous systems. It's a core technology that we view as very important. We sort of see it as the mother of all AI projects. It's probably one of the most difficult AI projects actually to work on\" said,Apple CEO Tim Cook. Whereas Tesla and Ford have a leg up with emphasis in the automotive industry, as John Engel emphasizes in his Seeking Alpha article, \"Ultimately, I see little about the automotive sector – EV or otherwise – that would make it a natural fit for Apple. While I suspect the development of the Apple Car over the next few years will act as a positive catalyst for Apple's stock, it will end up being more of a liability than an asset.\" Let's compare each of their growth and profitability grades.</p>\n<p><b>Ford Growth and Profitability vs. Tesla and Apple</b></p>\n<p>With plans to build over 600,000 EV's annually by 2025 and Ford CEO Jim Farley pushing for 40% of its vehicles to be battery powered by 2030, its transition to electric cars is proving to be successful. Led by its fully-electric Mustang Mach-EFord, Ford set a new September record with EV sales surging 92% from the previous year to 9,150. Adding insult to injury, Doug Field,\"One of the top product leaders from Apple, Tesla and Segway,\"left Apple after aiding in the launch of its electric vehicle, poached by Ford as their new Chief Advanced Technology Officer. Online speculation indicates that this move may be the final nail in the Apple EV coffin. While it's all speculation, as we compare the three EV makers, it's clear why we believe Ford will prove the victor and the EV stock to watch.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eec2355246ce651d0fb1df4614fcf9e5\" tg-width=\"640\" tg-height=\"255\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Ford has delivered a stock price increase of more than 62% over the last five years and an increase of more than 132% YTD, bringing both A- Growth and A+ Profitability Factor Grades. With a Very Bullish rating and continually evolving in the changing landscape of electric vehicles, Ford is set to continue delivering results in the vehicle sector. Ford is built tough and has been resilient despite chip shortages and the effects brought on by the pandemic. Ford continues to introduce new vehicles and will launch an all-electric F-150 Lightning in 2022 that possesses a maximum towing capacity of 10,000 pounds and a range of up to 300 miles. According to the CEO, there's a massive demand for this truck with 200,000 reservations.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/45b7946a5aed4f7f01a00c1ef0635628\" tg-width=\"640\" tg-height=\"254\" width=\"100%\" height=\"auto\"><span>Image Source: 2022 Ford® F-150 Lightning Electric Truck |All Electric and All F-150</span></p>\n<p>The American-made F-150 Lightning and its next-generation full-size electric pickup are developing in high volumes at its new facility in Blue Oval City, Tennessee. The numbers don't lie, and despite a semiconductor shortage, there's no shortage of buyers seeking Ford vehicles. The momentum is sure to continue, especially as Ford manages its partnership with GlobalFoundries and continues to make strides to outpace Tesla and Apple.</p>\n<p>While we continue to see vehicles generated by Ford, we have yet to see the release of an actual Apple EV. Tesla, on the other hand, the pioneer of the electric vehicle, continues to showcase why their cutting-edge battery technology is rated the best car in its class. It's no secret that Tesla continues to build cars for more and more people, making products accessible and affordable while also bridging the gap towards clean transport and renewable energy.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/85b3fbd9b4798b8e89ef154b6eb78098\" tg-width=\"640\" tg-height=\"339\" width=\"100%\" height=\"auto\"><span>Image Source: Model S</span></p>\n<p>We feel Ford's biggest contender in the EV space is Tesla, and Ford also contends that it will be the No. 2 EV producer in two years. Following a Ford EPS of $0.51 beats by $0.24 and 19 FY1 Up Revisions in the last 90 days, it's no wonder Ford is neck-to-neck with its competitors on Profitability with A+ ratings. Ford's continued strength indicates why Jim Farley, Ford CEO during the Q3 Earnings Call, said, \"We're moving aggressively to lead the electric vehicle revolution, substantially expanding our battery production as we speak today in the U.S. In fact, we already announced plans that will give us enough battery production to meet our mid-decade goal of 141 gigawatts, which is enough to build more than 1 million battery electric vehicles a year, and I think we'll need more.\"</p>\n<p><i><b>FORD EARNINGS AND REVISIONS</b></i></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d1077c0c6a7d52a3c5c3a553c5c5ac32\" tg-width=\"640\" tg-height=\"369\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p><b>Ford, Tesla, and Apple Momentum</b></p>\n<p>Each of the stocks, Ford, Tesla, and Apple continue to put their money where they believe there is an upside. Momentum is a successful trading strategy in which investors buy rising stocks and sell as they're retreating, and it is a vital factor for predicting stock price performance for those wanting to hold long term.</p>\n<p>Investor confidence remains high in the EV space, with each stock exhibiting A or better Momentum Grades. Year-to-date, Ford has remained up 57.27% over the previous three months while the sector is down nearly 5%. Tesla is up 30% and Apple more than 17%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/34c9ba651be822d98ff1d10c0ee70b3a\" tg-width=\"640\" tg-height=\"206\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5548abc16267f2b83467c1e652937cdd\" tg-width=\"640\" tg-height=\"202\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f87dd913db38101b4d1f4b255ee4d28c\" tg-width=\"640\" tg-height=\"207\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p><b>Conclusion: Ford</b><b><i>Is</i></b><b>Built Tough and an EV Stock To Watch</b></p>\n<p>Electric Vehicle stocks can make a great return on investment, especially if you can identify those with fair valuations, excellent fundamentals and capitalize on their growth and momentum. In addition, sectors linked to EVs like semiconductors can also be great stock picks. In the current environment, where each of these stock picks offers a good balance of growth and value, it's a great play to diversify your portfolio and ride the EV and semiconductor wave. With the better valuation and continued advancements and momentum, we believe that Ford is the most opportune of the EV stock picks, but it's up to you to decide for yourself.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Next Top Electric Vehicle Stock: Look Out Tesla And Apple</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Next Top Electric Vehicle Stock: Look Out Tesla And Apple\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 15:00 GMT+8 <a href=https://seekingalpha.com/article/4475255-the-next-top-electric-vehicle-stock-look-out-tesla-and-apple><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nSemiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Microchip Technology are EV semiconductor stocks to watch.\nThe auto sector took a beating during the ...</p>\n\n<a href=\"https://seekingalpha.com/article/4475255-the-next-top-electric-vehicle-stock-look-out-tesla-and-apple\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","F":"福特汽车","AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4475255-the-next-top-electric-vehicle-stock-look-out-tesla-and-apple","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162833574","content_text":"Summary\n\nSemiconductor stocks stand to gain from the global chip shortages. ON Semi, Qualcomm and Microchip Technology are EV semiconductor stocks to watch.\nThe auto sector took a beating during the pandemic but is rebounding. Some EV stocks look attractive given the political environment, rising gas prices, and expansion of charging stations.\nIn 2022, US auto sales are expected to increase to $16M from $15M. Top automaker Ford wants all-in on electric and is addressing the chip shortage their way.\nCompared to its EV rivals Tesla and Apple, Ford offers solid fundamentals, a reasonable valuation framework, excellent Quant Factor grades, upward earnings revisions, and incredible stock momentum.\n\nBill Pugliano/Getty Images News\nAutomobiles and Semiconductor Chip Shortage\nOver the last several years, the rapid growth of Electric Vehicles (EV) has been nothing short of astonishing. As Brendan Ahern said in his article,The Unstoppable EV Ecosystem And How To Invest, \"The past two years have seen tremendous excitement in the global electric vehicles (EVs) industry as new companies listed shares, Tesla (TSLA) was added to the S&P 500, global governments stepped up electrification commitments, and electric vehicle sales soared, especially in China and the EU.\" This overview sums up the progress of EVs in the auto sector.\nOur Top Automotive pick, Ford (F), is up 132% YTD and is in an enviable position on fundamentals at this time compared to Tesla, up 37% YTD. And despite Apple's (AAPL) accelerating plans for an autonomous vehicle, which they have deemed their mother of all Ai projects, so far, they are all talk with no viable EV product offering. Apple’s entry into the autonomous vehicle space is a topic of speculation. Notably, there is more than one way to invest in the EV revolution. It comes down to \"what’s inside?\"\nCars are like the new mainframe computers. A new car can have more than two thousand chips, blowing away a smartphone with perhaps four chips. Semiconductors play a significant role in today's automotive sector, especially EVs, which is why we find their stocks attractive. ON Semi (ON), Qualcomm (QCOM), and Microchip Technology (MCHP) are some of the best suppliers for the automotive sector. Supply chain constraints and Asian factory shutdowns have drastically impacted automotive sales. Despite the supply shortage, there's been high demand, and we've seen the cost of semiconductor shortages balloon above 90%, according to a Bloomberg News Article.\nWith a record 21 weeks to fill chip orders,Dan Hearsch, Managing Director of AlixPartners Automotive and Industrial Practice said, \"It certainly feels like the most protracted supply shortage the industry has seen because it's not over.\" Despite the lack of semiconductors, automotive prices continue to climb, reaching records in the U.S. over $42,000 per vehicle, making chip manufacturers like ON Semi, Qualcomm, and Microchip Technology Incorporated Very Bullish buys, especially given their demand in EVs.\nON Semiconductor Corporation\nON Semiconductor is a stock I recently wrote about in an article called Top 5 Tech Stocks For 2022. A Fortune 1000 Company, ON Semi is a semiconductor and leading power management provider that uses signal and custom device technologies for communications, automotive, computing, and other uses. EV advancements allow for increased use of semiconductors in-vehicle platforms' electronics content, improving occupant safety through imaging and sensor function technology; sensor functions by way of algorithms enable vehicles to take immediate action to avoid accidents. This electrification is also used in the powertrain and vehicle auxiliary systems, with semiconductor technology at the forefront.\nThe Seeking Alpha News Team recently reported ON Semi as a top pick at Citigroup. Citigroup analyst Christopher Danely said, \"With January's earnings season on the horizon, now is a prime time for investors to buy semiconductor stocks as chip-sector shortages don't appear to be getting better any time soon...Danelynotes that business conditions for the semiconductor industry have not been this strong since 1999 and 2000 and that \"many\" companies are booked solid with orders through 2022.\"\nON carries a C+ Valuation Grade, remaining attractive relative to its sector by more than 7.29%, at a Forward P/E of 22.43x. Additionally, ON's growth, profitability, and momentum metrics are attractive.\nSource: Seeking Alpha Premium\nMomentum is a strong A+ Grade for ON Semiconductor, as they continue to have stellar price returns, with a price-performance return over 10 years exceeding 700%. Diving into ON’s growth grades, the company has a strong year-over-year EBITDA Growth grade of A- at 134.70% above the sector, and EPS FWD Long Term grade of A+, 208% above the sector. As we continue to dive into semiconductors important to vehicle automation, there is another name in the chip industry helping increase the trend towards EVs.\nQualcomm\nQCOM gets a significant portion of its revenue from products aimed at the automotive sector. QCOM is already the world's biggest supplier of mobile phone chips, a wireless technology innovator, and 5G driver. The company has announced it will continue to expand into next-generation self-driving vehicles. SA news just reported Qualcomm could rally 25% higher in the next six months, according to Cerity Partners' Jim Lebenthal. Qualcomm, who already works with firms like Microsoft (MSFT) and Meta Platforms (FB), wants to grab hold of the EV market share, which is significantly higher than the phone chip industry, according to Cristiano Amon, QCOM President and CEO. In a November Press Release, Amon said, \"Our announcement with BMW today is the onset of a new era in automotive where two technology leaders have come together to design and develop…the next-generation automobile…we see an incredible number of changes in the industry that are driving things and putting Qualcomm at the intersection of demand for virtually every industry.\"\nWhen looking at QCOM's Factor Grades below, it's clear why we believe they are on solid footing.\nSource: Seeking Alpha Premium\nQCOM comes at a reasonable valuation, trading nearly 30% below its sector with a forward P/E of 17.27+; Forward PEG is almost 63% below the sector. The stock has strong growth, excellent profitability metrics, and many analysts increasing their earnings estimates. As fellow Seeking Alpha author Valuentum writes, \"Qualcomm's growth trajectory is supported by its push into the automotive arena and the IoT trend, which are expected to grow its total addressable market opportunity over the next decade.\"\nSource: Seeking Alpha Premium\nIn addition to its strong profitability, QCOM is one of the best dividend-paying technology stocks. QCOM has a Dividend Growth Grade of A+. Because the trend and rise in popularity of electric vehicles is not the only way to make money, we are emphasizing another top semiconductor leading the wave of rising EVs, Microchip Technology Incorporated (MCHP).\nMicrochip Technology Incorporated\nAnother top EV chip-maker is MCHP, whose chips are used in wireless apps and devices for power management. MCHP’s chips specifically designed for electric vehicles is the artificial intelligence used to centralize computing and navigation and the powertrains and charging systems. Rated Very Bullish, out of 557 of our Top Tech Stocks, MCHP is ranked in the top 10% of this screener and continues to be on an upward trajectory, as evidenced by its B+ Momentum Grade.\nSource: Seeking Alpha Premium\nFollowing recent Q2 Earnings results,Jefferies Financial Group, among other analysts, has increased their MCHP price target of $98 to $109, which implies a 22.7% upside. With an EPS of $1.07 that beat by $0.01 and Revenue of $1.65B beating nearly 26% YoY, it’s no wonder there are 21 FY1 Up Revisions in the last 90 days, prompting an A- Revisions Grade.\nSource: Seeking Alpha Premium\nAs we look to the EV sector capitalizing on the use of semiconductors and investors wanting to know more about stocks in this space, let us discuss Ford (F), who recently partnered with GlobalFoundries (GFS), a multinational semiconductor manufacturing and design company to address the semiconductor shortage, thus positioning themselves as the next prominent EV manufacturer to rival Tesla and Apple in the space.\nYTD F, AAPL, TSLA PRICE RETURN COMPARISON\nSource: Seeking Alpha Premium\nFord\nFord has been a differentiator since the invention of the automobile. Ford’s partnering with semiconductor company GlobalFoundries clarifies that it wants to lead the industry and evolve by all means necessary, striking deals with companies to source materials and the parts required to avoid supply chain disruptions. \"Semiconductor is going to become the defining line for differentiation in the automotive experience. I believe you're seeing automotive companies want to become what I would call more silicon aware. And that's exactly what Ford is doing in their MOU they signed with G.F. They want to first make sure that they understand the supply-demand dynamics… to make sure they influence the technology road maps for foundries so that the features that we create align with their needs,\"Tom Caulfield GFS CEO, Q3 2021 Earnings Call. So how does Ford compare to its E.V. rivals, Tesla and Apple, in the electric car race?\nFord Valuation vs. Tesla and Apple\nFord is undervalued with an overall valuation grade of C, forward P/E trading -25.82%, and the sector at 14.55X. The forward PEG ratio has an A+ grade, trading nearly 82% below the sector. When we compare Ford, Apple, and Tesla on Valuation, TSLA and AAPL receive an overall F Grade.\nCompared to Tesla and Apple with F Valuation Grades, both look unattractive on a PEG basis (P/E Ratio divided by EPS long-term growth). Tesla PEG of 3.52X is 263.70% above the sector, and Apple PEG of 2.81X, 70.78% above the sector.\nSource: Seeking Alpha Premium\nSeeking Alpha’s Valuation Grade provides a unique view of how much a company is worth relative to other stocks in the same sector. Thanks to dozens of underlying metrics, the grades provide an instant characterization of the strength or weakness of the metric compared to similar stocks. Ford looks attractive on a 0.17X PEG basis and is not overvalued compared to the sector, with a median PEG of 0.97X.\nSource: Seeking Alpha Premium\nWhile a C grade is not ideal, Ford still looks attractive. As a pioneer in its industry, it should fare well in the EV space. According to Aswath Damodaran,Professor of Finance at the Stern School of Business at N.Y. University, the Automotive and Truck sector is sitting pretty, with a current P/E of 164.37 based upon January 2021 data and expected growth of 18.8% over the next five years with a PEG ratio of 8.87.\nApple's announcement of a fully autonomous vehicle has turned heads, especially given its wide range of technology and persistent delays to the project.Apple Car Project is being led by Ai and machine learning Chief John Giannandrea. \"We're focusing on autonomous systems. It's a core technology that we view as very important. We sort of see it as the mother of all AI projects. It's probably one of the most difficult AI projects actually to work on\" said,Apple CEO Tim Cook. Whereas Tesla and Ford have a leg up with emphasis in the automotive industry, as John Engel emphasizes in his Seeking Alpha article, \"Ultimately, I see little about the automotive sector – EV or otherwise – that would make it a natural fit for Apple. While I suspect the development of the Apple Car over the next few years will act as a positive catalyst for Apple's stock, it will end up being more of a liability than an asset.\" Let's compare each of their growth and profitability grades.\nFord Growth and Profitability vs. Tesla and Apple\nWith plans to build over 600,000 EV's annually by 2025 and Ford CEO Jim Farley pushing for 40% of its vehicles to be battery powered by 2030, its transition to electric cars is proving to be successful. Led by its fully-electric Mustang Mach-EFord, Ford set a new September record with EV sales surging 92% from the previous year to 9,150. Adding insult to injury, Doug Field,\"One of the top product leaders from Apple, Tesla and Segway,\"left Apple after aiding in the launch of its electric vehicle, poached by Ford as their new Chief Advanced Technology Officer. Online speculation indicates that this move may be the final nail in the Apple EV coffin. While it's all speculation, as we compare the three EV makers, it's clear why we believe Ford will prove the victor and the EV stock to watch.\nSource: Seeking Alpha Premium\nFord has delivered a stock price increase of more than 62% over the last five years and an increase of more than 132% YTD, bringing both A- Growth and A+ Profitability Factor Grades. With a Very Bullish rating and continually evolving in the changing landscape of electric vehicles, Ford is set to continue delivering results in the vehicle sector. Ford is built tough and has been resilient despite chip shortages and the effects brought on by the pandemic. Ford continues to introduce new vehicles and will launch an all-electric F-150 Lightning in 2022 that possesses a maximum towing capacity of 10,000 pounds and a range of up to 300 miles. According to the CEO, there's a massive demand for this truck with 200,000 reservations.\nImage Source: 2022 Ford® F-150 Lightning Electric Truck |All Electric and All F-150\nThe American-made F-150 Lightning and its next-generation full-size electric pickup are developing in high volumes at its new facility in Blue Oval City, Tennessee. The numbers don't lie, and despite a semiconductor shortage, there's no shortage of buyers seeking Ford vehicles. The momentum is sure to continue, especially as Ford manages its partnership with GlobalFoundries and continues to make strides to outpace Tesla and Apple.\nWhile we continue to see vehicles generated by Ford, we have yet to see the release of an actual Apple EV. Tesla, on the other hand, the pioneer of the electric vehicle, continues to showcase why their cutting-edge battery technology is rated the best car in its class. It's no secret that Tesla continues to build cars for more and more people, making products accessible and affordable while also bridging the gap towards clean transport and renewable energy.\nImage Source: Model S\nWe feel Ford's biggest contender in the EV space is Tesla, and Ford also contends that it will be the No. 2 EV producer in two years. Following a Ford EPS of $0.51 beats by $0.24 and 19 FY1 Up Revisions in the last 90 days, it's no wonder Ford is neck-to-neck with its competitors on Profitability with A+ ratings. Ford's continued strength indicates why Jim Farley, Ford CEO during the Q3 Earnings Call, said, \"We're moving aggressively to lead the electric vehicle revolution, substantially expanding our battery production as we speak today in the U.S. In fact, we already announced plans that will give us enough battery production to meet our mid-decade goal of 141 gigawatts, which is enough to build more than 1 million battery electric vehicles a year, and I think we'll need more.\"\nFORD EARNINGS AND REVISIONS\nSource: Seeking Alpha Premium\nFord, Tesla, and Apple Momentum\nEach of the stocks, Ford, Tesla, and Apple continue to put their money where they believe there is an upside. Momentum is a successful trading strategy in which investors buy rising stocks and sell as they're retreating, and it is a vital factor for predicting stock price performance for those wanting to hold long term.\nInvestor confidence remains high in the EV space, with each stock exhibiting A or better Momentum Grades. Year-to-date, Ford has remained up 57.27% over the previous three months while the sector is down nearly 5%. Tesla is up 30% and Apple more than 17%.\nSource: Seeking Alpha Premium\nSource: Seeking Alpha Premium\nSource: Seeking Alpha Premium\nConclusion: FordIsBuilt Tough and an EV Stock To Watch\nElectric Vehicle stocks can make a great return on investment, especially if you can identify those with fair valuations, excellent fundamentals and capitalize on their growth and momentum. In addition, sectors linked to EVs like semiconductors can also be great stock picks. In the current environment, where each of these stock picks offers a good balance of growth and value, it's a great play to diversify your portfolio and ride the EV and semiconductor wave. With the better valuation and continued advancements and momentum, we believe that Ford is the most opportune of the EV stock picks, but it's up to you to decide for yourself.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690343729,"gmtCreate":1639642161719,"gmtModify":1639642205735,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Really","listText":"Really","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690343729","repostId":"1127770254","repostType":4,"isVote":1,"tweetType":1,"viewCount":1422,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604421493,"gmtCreate":1639440410708,"gmtModify":1639440410893,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604421493","repostId":"2191984334","repostType":4,"isVote":1,"tweetType":1,"viewCount":1304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604421241,"gmtCreate":1639440365158,"gmtModify":1639440365342,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Really ","listText":"Really ","text":"Really","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604421241","repostId":"1165575464","repostType":4,"repost":{"id":"1165575464","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639387544,"share":"https://www.laohu8.com/m/news/1165575464?lang=&edition=full","pubTime":"2021-12-13 17:25","market":"us","language":"en","title":"5 Stocks To Watch For December 13, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1165575464","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Qudian Inc. to repor","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b>Qudian Inc.</b> to report quarterly earnings at $0.34 per share on revenue of $117.22 million before the opening bell. Qudian shares rose 2.9% to close at $1.40 on Friday.</li>\n <li><b>SIFCO Industries, Inc.</b> reported a net loss of $0.43 per share for the fourth quarter of fiscal 2021, versus year-ago net income of $0.86 per share. Its net sales dropped 16.3% to $24.3 million. SIFCO Industries shares fell 0.5% to close at $8.76 on Friday.</li>\n <li>Analysts are expecting <b>J.Jill, Inc.</b> to have earned $0.34 per share on revenue of $117.22 million for the latest quarter. J.Jill will release earnings after the markets close. Johnson Outdoors shares slipped 0.8% to close at $15.39 on Friday.</li>\n</ul>\n<ul>\n <li><b>Proto Labs Inc</b> announced a $50 million increase to its stock buyback plan. The recent authorization raises the repurchase program to $150 million. Proto Labs shares gained 0.9% to $50.02 in the after-hours trading session.</li>\n <li>Analysts expect <b>Zedge, Inc.</b> to post quarterly earnings at $0.12 per share on revenue of $5.26 million after the closing bell. Zedge shares dropped 0.9% to $9.16 in after-hours trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 13, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 13, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-13 17:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b>Qudian Inc.</b> to report quarterly earnings at $0.34 per share on revenue of $117.22 million before the opening bell. Qudian shares rose 2.9% to close at $1.40 on Friday.</li>\n <li><b>SIFCO Industries, Inc.</b> reported a net loss of $0.43 per share for the fourth quarter of fiscal 2021, versus year-ago net income of $0.86 per share. Its net sales dropped 16.3% to $24.3 million. SIFCO Industries shares fell 0.5% to close at $8.76 on Friday.</li>\n <li>Analysts are expecting <b>J.Jill, Inc.</b> to have earned $0.34 per share on revenue of $117.22 million for the latest quarter. J.Jill will release earnings after the markets close. Johnson Outdoors shares slipped 0.8% to close at $15.39 on Friday.</li>\n</ul>\n<ul>\n <li><b>Proto Labs Inc</b> announced a $50 million increase to its stock buyback plan. The recent authorization raises the repurchase program to $150 million. Proto Labs shares gained 0.9% to $50.02 in the after-hours trading session.</li>\n <li>Analysts expect <b>Zedge, Inc.</b> to post quarterly earnings at $0.12 per share on revenue of $5.26 million after the closing bell. Zedge shares dropped 0.9% to $9.16 in after-hours trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SIF":"SIFCO Industries Inc","JILL":"J.Jill Inc.","PRLB":"Proto Labs Inc","QD":"趣店","ZDGE":"Zedge, Inc. Class B"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165575464","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Qudian Inc. to report quarterly earnings at $0.34 per share on revenue of $117.22 million before the opening bell. Qudian shares rose 2.9% to close at $1.40 on Friday.\nSIFCO Industries, Inc. reported a net loss of $0.43 per share for the fourth quarter of fiscal 2021, versus year-ago net income of $0.86 per share. Its net sales dropped 16.3% to $24.3 million. SIFCO Industries shares fell 0.5% to close at $8.76 on Friday.\nAnalysts are expecting J.Jill, Inc. to have earned $0.34 per share on revenue of $117.22 million for the latest quarter. J.Jill will release earnings after the markets close. Johnson Outdoors shares slipped 0.8% to close at $15.39 on Friday.\n\n\nProto Labs Inc announced a $50 million increase to its stock buyback plan. The recent authorization raises the repurchase program to $150 million. Proto Labs shares gained 0.9% to $50.02 in the after-hours trading session.\nAnalysts expect Zedge, Inc. to post quarterly earnings at $0.12 per share on revenue of $5.26 million after the closing bell. Zedge shares dropped 0.9% to $9.16 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1485,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604279292,"gmtCreate":1639407389820,"gmtModify":1639407390372,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604279292","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605690209,"gmtCreate":1639149465713,"gmtModify":1639149465835,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Wow ","listText":"Wow ","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605690209","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602415427,"gmtCreate":1639056708676,"gmtModify":1639057201069,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602415427","repostId":"1117677376","repostType":4,"repost":{"id":"1117677376","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639041481,"share":"https://www.laohu8.com/m/news/1117677376?lang=&edition=full","pubTime":"2021-12-09 17:18","market":"us","language":"en","title":"Pear Therapeutics shares soared 75% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1117677376","media":"Tiger Newspress","summary":"Pear Therapeutics shares soared 75% in premarket trading.\n\nPrescription digital therapeutics company","content":"<p>Pear Therapeutics shares soared 75% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/1aa8562d3d7942fc80a42167c422600c\" tg-width=\"851\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Prescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.</p>\n<p>The business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.</p>\n<p>\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\" Pear President and CEO Dr. Corey McCann said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pear Therapeutics shares soared 75% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPear Therapeutics shares soared 75% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-09 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pear Therapeutics shares soared 75% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/1aa8562d3d7942fc80a42167c422600c\" tg-width=\"851\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p>Prescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.</p>\n<p>The business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.</p>\n<p>\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\" Pear President and CEO Dr. Corey McCann said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PEAR":"Pear Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117677376","content_text":"Pear Therapeutics shares soared 75% in premarket trading.\n\nPrescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.\nThe business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.\n\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\" Pear President and CEO Dr. Corey McCann said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":1055,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602415115,"gmtCreate":1639056629754,"gmtModify":1639057198835,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602415115","repostId":"1192937541","repostType":4,"repost":{"id":"1192937541","kind":"news","pubTimestamp":1639045976,"share":"https://www.laohu8.com/m/news/1192937541?lang=&edition=full","pubTime":"2021-12-09 18:32","market":"us","language":"en","title":"U.S. Stock Futures Wobble on Omicron Restrictions","url":"https://stock-news.laohu8.com/highlight/detail?id=1192937541","media":"Wall Street Journal","summary":"U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit th","content":"<p>U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit the spread of the Omicron variant.</p>\n<p>Futures tied to the S&P 500 retreated 0.3% Thursday, suggesting the broad-market index is set to pull back moderately after closing up 0.3% Wednesday. Dow Jones Industrial Average futures also slid 0.3% and Nasdaq-100 futures ticked down 0.2%.</p>\n<p>Stocks have swung in recent weeks, buffeted by conflicting headlines on the Omicron coronavirus variant and mixed signals on the health of the economy. Investors are still awaiting further data on the strain’s severity and vaccine efficacy. Some pharmaceutical companies including Pfizer and Glaxo Smith Kline have said this week that their shot and antibody treatment appears to work in early-stage studies.</p>\n<p>European governments have moved to tighten restrictions, spurring concerns about setbacks to the economic recovery. U.K. Prime Minister Johnson outlined a new work-from-home mandate and mask guidelines on Wednesday evening. A study released by a Japanese scientist said the variant was four times more transmissible than the Delta strain.</p>\n<p>“There’s still a lot we don’t know, we’re waiting for details to emerge,” said Arun Sai, a multi-asset strategist at Pictet Asset Management. On restrictions, “as long as it’s temporary, it doesn’t completely derail the recovery. We now know the playbook. We’re talking about a one or two quarter postponement of a recovery in services, that’s the critical element that’s at risk here.”</p>\n<p>The yield on the benchmark 10-year Treasury note edged down to 1.494% Thursday from 1.508% Wednesday.</p>\n<p>China’s producer-price index showed a 12.9% increase in November from a year earlier, a decline from the previous month but still more than economists expected. Consumer prices also rose.</p>\n<p>“Factory gate prices only showed modest signs of slowing,” which may signal that higher inflation will remain in place in the coming months, said Michael Hewson, a chief markets analyst at CMC Markets. China’s producer prices drive consumer prices around the world, he added.</p>\n<p>In Asia, major benchmarks were mixed. The Shanghai Composite Index advanced 1%, while Hong Kong’s Hang Seng Index climbed 1.1%. Japan’s Nikkei 225 slid 0.5%, boosted by gains in technology stocks.</p>\n<p>In Europe, the pan-continental Stoxx Europe 600 ticked up 0.2%. Rolls Royce shares declined 4.4% after the company released an update that showed it had a long way to go before meeting its cash-flow target and which will depend on international travel being allowed, Mr. Hewson said.</p>\n<p>In the U.S., cloud-computing firmOracle, network company Broadcom and wholesaler Costco are set to report Thursday after market close. Popular meme stock GameStop declined 3.2% in off-hours trading after the company posted earnings that showed a widening loss last quarter.</p>\n<p>“Earnings have been strong overall, it’s a really positive underlying driver for equity markets,” said Kiran Ganesh, a multi-asset strategist at UBS Global Wealth Management.</p>\n<p>Shares of Amazon.com declined 0.2% premarket after the Italian government fined it $1.3 billion for alleged abuse of market dominance. The European Union is also investigating the e-commerce giant in a similar antitrust case.</p>\n<p>Fresh data on U.S. jobless claims, a proxy for layoffs, is set to go out at 8:30 a.m. ET. Economists are forecasting that the level will remain near pandemic lows. It has come close to the pre-pandemic average in recent weeks in a sign that the labor market is improving.</p>\n<p>Oil prices wavered between small gains and losses. Global benchmark Brent crude declined 0.2% and traded at $75.61 a barrel. It has risen more than 8% this week, lifted by early indications that the Omicron variant may not weigh on energy demand as much as feared, according to analysts at ANZ.</p>\n<p>Bitcoin reversed direction after four days of gains, slipping 2% from its level at 5 p.m. Wednesday. It traded below $50,000, a 28% drop from its record high set in November.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Futures Wobble on Omicron Restrictions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Futures Wobble on Omicron Restrictions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 18:32 GMT+8 <a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-09-2021-11639038586?mod=markets_lead_pos4><strong>Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit the spread of the Omicron variant.\nFutures tied to the S&P 500 retreated 0.3% Thursday, suggesting the...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-09-2021-11639038586?mod=markets_lead_pos4\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-09-2021-11639038586?mod=markets_lead_pos4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192937541","content_text":"U.S. stock futures edged down as investors assessed the latest headlines on restrictions to limit the spread of the Omicron variant.\nFutures tied to the S&P 500 retreated 0.3% Thursday, suggesting the broad-market index is set to pull back moderately after closing up 0.3% Wednesday. Dow Jones Industrial Average futures also slid 0.3% and Nasdaq-100 futures ticked down 0.2%.\nStocks have swung in recent weeks, buffeted by conflicting headlines on the Omicron coronavirus variant and mixed signals on the health of the economy. Investors are still awaiting further data on the strain’s severity and vaccine efficacy. Some pharmaceutical companies including Pfizer and Glaxo Smith Kline have said this week that their shot and antibody treatment appears to work in early-stage studies.\nEuropean governments have moved to tighten restrictions, spurring concerns about setbacks to the economic recovery. U.K. Prime Minister Johnson outlined a new work-from-home mandate and mask guidelines on Wednesday evening. A study released by a Japanese scientist said the variant was four times more transmissible than the Delta strain.\n“There’s still a lot we don’t know, we’re waiting for details to emerge,” said Arun Sai, a multi-asset strategist at Pictet Asset Management. On restrictions, “as long as it’s temporary, it doesn’t completely derail the recovery. We now know the playbook. We’re talking about a one or two quarter postponement of a recovery in services, that’s the critical element that’s at risk here.”\nThe yield on the benchmark 10-year Treasury note edged down to 1.494% Thursday from 1.508% Wednesday.\nChina’s producer-price index showed a 12.9% increase in November from a year earlier, a decline from the previous month but still more than economists expected. Consumer prices also rose.\n“Factory gate prices only showed modest signs of slowing,” which may signal that higher inflation will remain in place in the coming months, said Michael Hewson, a chief markets analyst at CMC Markets. China’s producer prices drive consumer prices around the world, he added.\nIn Asia, major benchmarks were mixed. The Shanghai Composite Index advanced 1%, while Hong Kong’s Hang Seng Index climbed 1.1%. Japan’s Nikkei 225 slid 0.5%, boosted by gains in technology stocks.\nIn Europe, the pan-continental Stoxx Europe 600 ticked up 0.2%. Rolls Royce shares declined 4.4% after the company released an update that showed it had a long way to go before meeting its cash-flow target and which will depend on international travel being allowed, Mr. Hewson said.\nIn the U.S., cloud-computing firmOracle, network company Broadcom and wholesaler Costco are set to report Thursday after market close. Popular meme stock GameStop declined 3.2% in off-hours trading after the company posted earnings that showed a widening loss last quarter.\n“Earnings have been strong overall, it’s a really positive underlying driver for equity markets,” said Kiran Ganesh, a multi-asset strategist at UBS Global Wealth Management.\nShares of Amazon.com declined 0.2% premarket after the Italian government fined it $1.3 billion for alleged abuse of market dominance. The European Union is also investigating the e-commerce giant in a similar antitrust case.\nFresh data on U.S. jobless claims, a proxy for layoffs, is set to go out at 8:30 a.m. ET. Economists are forecasting that the level will remain near pandemic lows. It has come close to the pre-pandemic average in recent weeks in a sign that the labor market is improving.\nOil prices wavered between small gains and losses. Global benchmark Brent crude declined 0.2% and traded at $75.61 a barrel. It has risen more than 8% this week, lifted by early indications that the Omicron variant may not weigh on energy demand as much as feared, according to analysts at ANZ.\nBitcoin reversed direction after four days of gains, slipping 2% from its level at 5 p.m. Wednesday. It traded below $50,000, a 28% drop from its record high set in November.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602300738,"gmtCreate":1638966528449,"gmtModify":1638966528566,"author":{"id":"4092737844653660","authorId":"4092737844653660","name":"Hk01","avatar":"https://static.tigerbbs.com/47f73b69bc4bb694a9b2dedd17efba98","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4092737844653660","idStr":"4092737844653660"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602300738","repostId":"1177589023","repostType":4,"repost":{"id":"1177589023","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964838,"share":"https://www.laohu8.com/m/news/1177589023?lang=&edition=full","pubTime":"2021-12-08 20:00","market":"us","language":"en","title":"Pfizer, BioNTech say third dose neutralizes Omicron variant","url":"https://stock-news.laohu8.com/highlight/detail?id=1177589023","media":"Tiger Newspress","summary":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on ","content":"<p>Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc. and BioNTech SE today announced results from an initial <i>laboratory</i> study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said <b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said <b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech say third dose neutralizes Omicron variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech say third dose neutralizes Omicron variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 20:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.</p>\n<p><img src=\"https://static.tigerbbs.com/896ce4e657b0942d9d7a0abce1c3d2f7\" tg-width=\"853\" tg-height=\"622\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/35c4bf42aa2936640aedd52e01beebc5\" tg-width=\"853\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li><i>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers</i></li>\n <li><i>Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection</i></li>\n <li><i>As 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease</i></li>\n <li><i>The companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022</i></li>\n</ul>\n<p>Pfizer Inc. and BioNTech SE today announced results from an initial <i>laboratory</i> study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.</p>\n<p>Sera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.</p>\n<p>A more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.</p>\n<p>“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said <b>Albert Bourla, Chairman and Chief Executive Officer, Pfizer</b>. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”</p>\n<p>“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said <b>Ugur Sahin, M.D., CEO and Co-Founder of BioNTech</b>. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”</p>\n<p>While these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177589023","content_text":"Pfizer and biontech stocks narrowed their losses in premarket trading after they provided update on Omicron variant.\n\n\nPreliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers\nData indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection\nAs 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease\nThe companies continue to advance the development of a variant-specific vaccine for Omicron and expect to have it available by March in the event that an adaption is needed to further increase the level and duration of protection – with no change expected to the companies’ four billion dose capacity for 2022\n\nPfizer Inc. and BioNTech SE today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses. Sera obtained from vaccinees one month after receiving the booster vaccination (third dose of BNT162b2 vaccine) neutralized the Omicron variant to levels that are comparable to thoseobserved for the wild-type SARS-CoV-2 spike protein after two doses.\nSera from individuals who received two doses of the current COVID-19 vaccine did exhibit, on average, more than a 25-fold reduction in neutralization titers against the Omicron variant compared to wild-type, indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant. However, as the vast majority of epitopes targeted by vaccine-induced T cells are not affected by the mutations in Omicron, the companies believe that vaccinated individuals may still be protected against severe forms of the disease and are closely monitoring real world effectiveness against Omicron, globally.\nA more robust protection may be achieved by a third dose as data from additional studies of the companies indicate that a booster with the current COVID-19 vaccine from Pfizer and BioNTech increases the antibody titers by 25-fold. According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron. These antibody levels are associated with high efficacy against both the wild-type virus and these variants. A third dose also strongly increases CD8+T cell levels against multiple spike protein epitopes which are considered to correlate with the protection against severe disease. Compared to the wild-type virus, the vast majority of these epitopes remain unchanged in the Omicron spike variant.\n“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of our vaccine,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Ensuring as many people as possible are fully vaccinated with the first two dose series and a booster remains the best course of action to prevent the spread of COVID-19.”\n“Our preliminary, first dataset indicate that a third dose could still offer a sufficient level of protection from disease of any severity caused by the Omicron variant,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season. We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine.”\nWhile these results are preliminary, the companies will continue to collect more laboratory data and evaluate real-world effectiveness to assess and confirm protection against Omicron and inform the most effective path forward. On November 25, the companies started to develop an Omicron-specific COVID-19 vaccine. The development will continue as planned in the event that a vaccine adaption is needed to increase the level and duration of protection against Omicron. First batches of the Omicron-based vaccine can be produced and are planned to be ready for deliveries within 100 days, pending regulatory approval. Pfizer and BioNTech have tested other variant-specific vaccines as well, which have produced very strong neutralization titers and a tolerable safety profile. Based on this experience the companies have high confidence that if needed they can deliver an Omicron-based vaccine in March 2022. The companies have also previously initiated clinical trials with variant-specific vaccines (Alpha, Beta, Delta & Alpha/Delta Mix) and data from these studies will be submitted to regulatory agencies around the world to help accelerate the process of adapting the vaccine and gaining regulatory authorization or approval of an Omicron-specific vaccine, if needed. The companies have previously announced that they expect to produce four billion doses of BNT162b2 in 2022, and this capacity is not expected to change if an adapted vaccine is required.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}